4.01
price up icon2.56%   0.10
after-market Handel nachbörslich: 3.98 -0.03 -0.75%
loading
Schlusskurs vom Vortag:
$3.91
Offen:
$3.91
24-Stunden-Volumen:
636.39K
Relative Volume:
1.08
Marktkapitalisierung:
$123.03M
Einnahmen:
$875.70K
Nettoeinkommen (Verlust:
$-39.57M
KGV:
-2.9874
EPS:
-1.3423
Netto-Cashflow:
$-33.65M
1W Leistung:
+1.26%
1M Leistung:
+18.29%
6M Leistung:
+79.82%
1J Leistung:
+32.78%
1-Tages-Spanne:
Value
$3.85
$4.1254
1-Wochen-Bereich:
Value
$3.82
$4.39
52-Wochen-Spanne:
Value
$1.90
$4.39

Vistagen Therapeutics Inc Stock (VTGN) Company Profile

Name
Firmenname
Vistagen Therapeutics Inc
Name
Telefon
650-577-3600
Name
Adresse
343 ALLERTON AVENUE, SOUTH SAN FRANCISCO
Name
Mitarbeiter
57
Name
Twitter
@vistagen
Name
Nächster Verdiensttermin
2024-11-07
Name
Neueste SEC-Einreichungen
Name
VTGN's Discussions on Twitter

Vergleichen Sie VTGN mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
VTGN
Vistagen Therapeutics Inc
4.01 119.96M 875.70K -39.57M -33.65M -1.3423
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
412.22 104.45B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
469.36 60.95B 2.46B -319.09M -52.09M -2.4669
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
572.60 59.11B 14.21B 4.46B 3.56B 39.69
Biotechnology icon
ARGX
Argen X Se Adr
812.95 49.23B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
ONC
Beone Medicines Ltd Adr
320.94 35.92B 4.56B -176.77M 225.30M -1.7177

Vistagen Therapeutics Inc Stock (VTGN) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2023-12-07 Hochstufung Jefferies Hold → Buy
2023-08-07 Hochstufung Maxim Group Hold → Buy
2022-07-22 Herabstufung Jefferies Buy → Hold
2022-07-22 Herabstufung Robert W. Baird Outperform → Neutral
2022-07-22 Herabstufung William Blair Outperform → Mkt Perform
2021-05-20 Eingeleitet Robert W. Baird Outperform
2021-02-18 Eingeleitet Jefferies Buy
2021-01-04 Hochstufung William Blair Mkt Perform → Outperform
2018-06-27 Eingeleitet Maxim Group Buy
2018-02-08 Bestätigt Chardan Capital Markets Buy
2017-03-28 Eingeleitet Maxim Group Buy
Alle ansehen

Vistagen Therapeutics Inc Aktie (VTGN) Neueste Nachrichten

pulisher
06:59 AM

Will Vistagen Therapeutics Inc. stock gain from strong economyMarket Movement Recap & Expert Approved Momentum Ideas - newser.com

06:59 AM
pulisher
05:10 AM

Tools to assess Vistagen Therapeutics Inc.’s risk profileJuly 2025 Retail & Weekly High Return Stock Opportunities - newser.com

05:10 AM
pulisher
02:01 AM

What institutional flow reveals about Vistagen Therapeutics Inc.July 2025 Trade Ideas & Real-Time Volume Trigger Notifications - newser.com

02:01 AM
pulisher
Oct 13, 2025

How to recover losses in Vistagen Therapeutics Inc. stockPortfolio Return Report & Free Technical Confirmation Trade Alerts - newser.com

Oct 13, 2025
pulisher
Oct 13, 2025

Vistagen Therapeutics Inc. stock momentum explainedWeekly Loss Report & High Return Stock Watch Alerts - newser.com

Oct 13, 2025
pulisher
Oct 13, 2025

Combining machine learning predictions for Vistagen Therapeutics Inc.July 2025 Weekly Recap & Free Safe Entry Trade Signal Reports - newser.com

Oct 13, 2025
pulisher
Oct 12, 2025

Applying Elliott Wave Theory to Vistagen Therapeutics Inc.Quarterly Trade Review & Weekly Market Pulse Updates - newser.com

Oct 12, 2025
pulisher
Oct 11, 2025

VistaGen Therapeutics’ (VTGN) “Sell (D-)” Rating Reiterated at Weiss Ratings - Defense World

Oct 11, 2025
pulisher
Oct 10, 2025

Published on: 2025-10-10 09:33:10 - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Using Ichimoku Cloud for Vistagen Therapeutics Inc. technicalsExit Point & Intraday High Probability Setup Alerts - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Published on: 2025-10-10 04:25:39 - newser.com

Oct 10, 2025
pulisher
Oct 09, 2025

VistaGen Therapeutics (NASDAQ:VTGN) Given "Sell (D-)" Rating at Weiss Ratings - MarketBeat

Oct 09, 2025
pulisher
Oct 09, 2025

What MACD and RSI say about Vistagen Therapeutics Inc.July 2025 Fed Impact & Scalable Portfolio Growth Methods - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

We Think Vistagen Therapeutics (NASDAQ:VTGN) Needs To Drive Business Growth Carefully - Sahm

Oct 09, 2025
pulisher
Oct 09, 2025

Advanced analytics toolkit walkthrough for Vistagen Therapeutics Inc.July 2025 Short Interest & AI Powered Buy/Sell Recommendations - newser.com

Oct 09, 2025
pulisher
Oct 07, 2025

High Stakes Ahead: Vistagen's Fasedienol Trials Could Make Or Break The Story - RTTNews

Oct 07, 2025
pulisher
Oct 06, 2025

Sector ETF performance correlation with Vistagen Therapeutics Inc.July 2025 Closing Moves & High Yield Stock Recommendations - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

How moving averages guide Vistagen Therapeutics Inc. trading2025 Winners & Losers & High Accuracy Investment Entry Signals - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

Detecting price anomalies in Vistagen Therapeutics Inc. with AIMarket Growth Review & Free Fast Gain Swing Trade Alerts - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

Has Vistagen Therapeutics Inc. found a price floorJuly 2025 Action & Fast Entry and Exit Trade Plans - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

Understanding Vistagen Therapeutics Inc.’s price movement2025 Top Decliners & Verified Stock Trade Ideas - newser.com

Oct 06, 2025
pulisher
Oct 05, 2025

Full technical analysis of Vistagen Therapeutics Inc. stockJuly 2025 Setups & Entry and Exit Point Strategies - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

Vistagen Therapeutics Inc. stock daily chart insightsJuly 2025 PreEarnings & Real-Time Volume Surge Alerts - newser.com

Oct 05, 2025
pulisher
Oct 03, 2025

What’s the recovery path for long term holders of Vistagen Therapeutics Inc.Share Buyback & Verified Momentum Stock Watchlist - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

How high can Vistagen Therapeutics Inc. stock go2025 Market Sentiment & Free Safe Capital Growth Stock Tips - newser.com

Oct 03, 2025
pulisher
Oct 01, 2025

Vistagen Therapeutics Inc Stock Analysis and ForecastHigh Frequency Trading Trends & Access High Yield Alerts - earlytimes.in

Oct 01, 2025
pulisher
Oct 01, 2025

Acute Social Anxiety Disorder Market on Track for Major Expansion by 2034, According to DelveInsight | GlaxoSmithKline Plc, Viatris Inc, Johnson & Johnson, Novartis AG, Pfizer Inc, AstraZeneca Plc - Barchart.com

Oct 01, 2025
pulisher
Sep 30, 2025

Tools to monitor Vistagen Therapeutics Inc. recovery probabilityWatch List & Target Return Focused Picks - newser.com

Sep 30, 2025

Finanzdaten der Vistagen Therapeutics Inc-Aktie (VTGN)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$21.75
price down icon 5.15%
$85.96
price up icon 1.45%
$32.75
price up icon 0.21%
$102.61
price up icon 0.30%
$161.38
price down icon 1.56%
biotechnology ONC
$320.94
price down icon 1.86%
Kapitalisierung:     |  Volumen (24h):